Siemens Healthineers Says Covid-19 Rapid Test Gets U.S. Authorization
30 Dezember 2021 - 9:54AM
Dow Jones News
By Joshua Kirby
Siemens Healthineers AG said late Wednesday that its Covid-19
rapid self-test has been cleared for use in the U.S. and should be
available there beginning next month.
The German medical-equipment maker said its nasal antigen
Clinitest was granted emergency-use authorization by the U.S. Food
and Drug Administration.
The test, which can be bought over the counter and
self-administered, should be available beginning in January, with
production capacity for the U.S. market reaching tens of millions
of tests monthly, Siemens Healthineers said.
Write to Joshua Kirby at joshua.kirby@wsj.com;
@joshualeokirby
(END) Dow Jones Newswires
December 30, 2021 03:39 ET (08:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Siemens Healthineers (TG:SHL)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Siemens Healthineers (TG:SHL)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
